title: Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese.
abstract: BACKGROUND
  Mutations in the glucocerebrosidase (GBA) gene have recently been identified as contributing to the development of Parkinson disease (PD) in Ashkenazi Jews.
  
  
  METHODS
  To investigate whether this finding can be confirmed in a Taiwanese population, we conducted a case control study in a cohort of 518 PD patients and 339 controls for the three common GBA mutations in Taiwan, L444P, RecNciI and R120W, using PCR restriction enzyme assay and DNA sequencing.
  
  
  RESULTS
  Heterozygous GBA mutations were detected in 16 PD patients (3.1%) and four controls (1.2%). Although this difference was not statistically significant (p = 0.0703), the average age at disease onset of the 16 PD patients (50.6 (12.3) years) was significantly younger than that of the total patient group (63.8 (10.5) years; p = 0.0007) and the non-carrier patient group (64.2 (10.2) years; p = 0.0005). After stratification by age, the frequency of mutation carriers was significantly higher for the early onset PD (EOPD, age at onset < or = 50 years) group than for age matched controls (12.9% vs 1.8%; p = 0.0335) and there was a trend towards an increased risk of the mutation carrier with EOPD (odds ratio 8.30; 95% CI 1.45 to 156.53). Clinically, all 16 patients carrying a GBA mutation presented with a typical parkinsonian phenotype and experienced a good or excellent response to levodopa.
  
  
  CONCLUSIONS
  Mutations of the GBA gene may be associated with the development of EOPD in Taiwan.
authors: Department of Neurology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan.
authors: Yih-Ru
authors: YR
authors: Wu
authors: Chiung-Mei
authors: CM
authors: Chen
authors: Chih-Ying
authors: CY
authors: Chao
authors: Long-Sun
authors: LS
authors: Ro
authors: Rong-Kuo
authors: RK
authors: Lyu
authors: Kuo-Hsuan
authors: KH
authors: Chang
authors: Guey-Jen
authors: GJ
authors: Lee-Chen
mesh_terms: D000328:Adult; D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D044466:Asian People / Q000235:genetics*; D016022:Case-Control Studies; D015331:Cohort Studies; D005260:Female; D005962:Glucosylceramidase / Q000235:genetics*; D006579:Heterozygote; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D010300:Parkinson Disease / Q000208:ethnology* / Q000235:genetics*; D012307:Risk Factors; D013624:Taiwan
chemical_list: D005962:Glucosylceramidase
references: Ann Neurol. 2003;53 Suppl 3:S16-23; discussion S23-5
references: 12666095
references: Clin Genet. 2004 Feb;65(2):77-86
references: 14984463
references: Biochemistry. 2004 Apr 27;43(16):4810-8
references: 15096050
references: Science. 2004 Aug 27;305(5688):1292-5
references: 15333840
references: Genomics. 1989 Jan;4(1):87-96
references: 2914709
references: Neuropathol Appl Neurobiol. 1989 Jan-Feb;15(1):27-44
references: 2542825
references: Blood Cells Mol Dis. 2006 May-Jun;36(3):422-5
references: 16546416
references: N Engl J Med. 2004 Nov 4;351(19):1972-7
references: 15525722
references: Mov Disord. 2005 Mar;20(3):367-70
references: 15517592
references: Curr Opin Neurol. 2005 Aug;18(4):363-9
references: 16003110
references: Neurology. 2005 Nov 8;65(9):1460-1
references: 16148263
references: Neurology. 2006 Feb 14;66(3):415-7
references: 16476943
references: J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
references: 1564476